TRexBio - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeTRexBio
TRexBio logo

TRexBio

0 followers

About TRexBio

TRex Bio is a biotechnology company focused on mapping human tissue immunobiology to identify therapeutics for immune-mediated diseases. They leverage a Deep Biology Platform to map regulatory T cell (Treg) behavior in human tissue and link dysregulation to disease. By combining high-throughput sequencing, computational tools, and disease-relevant human assays, they develop tissue-focused, first-in-class therapeutics aimed at restoring tissue homeostasis. The company emphasizes translational immunology and collaborative drug discovery to address inflammatory and autoimmune conditions.

Recent News

Recent Deals

Key Team Members

Johnston Erwin

Chief Executive Officer

Brandon Hants

Chief Financial Officer

Laura Berner

Chief Operating Officer

Ali Zarrin

Chief Scientific Officer

Ariella Kelman

Chief Medical Officer

Key Facts

HQ Location

South San Francisco, United States

Founded

2018

Employees

51 - 200

Status

Private

Website

https://trex.bio